Literature DB >> 7052139

Purification and characterization of sepiapterin reductase from rat erythrocytes.

T Sueoka, S Katoh.   

Abstract

Sepiapterin reductase from rat erythrocyte hemolysate was purified 2000-fold to apparent homogeneity with 30% yield. The specific activity of the purified enzyme was 18 units/mg protein, and its molecular weight was 55 000. The enzyme consists of two identical subunits, each of which has a molecular weight of 27 500. The enzyme showed a single peak by isoelectric focusing with a pI of 4.9 and partial specific volume of 0.73 cm3/g. The amino acid composition was determined. pH optimum of the enzyme was 5.5. The equilibrium constant of 2.2.10(9) of the enzyme showed that the equilibrium lies much in favor of dihydrobiopterin formation from sepiapterin in rat erythrocytes. From steady-state kinetic measurements, ordered bi-bi mechanism was proposed to the reaction of sepiapterin reductase in which NADPH binds to free enzyme and sepiapterin binds next. NADP+ is released after the release of dihydrobiopterin. The Km values for sepiapterin and NADPH were 15.4 microM and 1.7 microM, respectively, and the Vmax value was 21.7 mumol/min per mg.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7052139     DOI: 10.1016/0304-4165(82)90178-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.

Authors:  L Bonafé; B Thöny; J M Penzien; B Czarnecki; N Blau
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

2.  Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: absence of phosphate-eliminating enzyme activity demonstrated in liver.

Authors:  A Niederwieser; W Leimbacher; H C Curtius; A Ponzone; F Rey; D Leupold
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

3.  The effect of age on tetrahydrobiopterin metabolism in the human brain.

Authors:  J Anderson; J A Blair; R A Armstrong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

4.  Liver enzyme activities in hyperphenylalaninaemia due to a defective synthesis of tetrahydrobiopterin.

Authors:  J L Dhondt; R G Cotton; D M Danks
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

5.  Sepiapterin reductase producing L-threo-dihydrobiopterin from Chlorobium tepidum.

Authors:  S H Cho; J U Na; H Youn; C S Hwang; C H Lee; S O Kang
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

6.  Isolation and expression of rat liver sepiapterin reductase cDNA.

Authors:  B A Citron; S Milstien; J C Gutierrez; R A Levine; B L Yanak; S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Biochemical characterization of the tetrahydrobiopterin synthesis pathway in the oleaginous fungus Mortierella alpina.

Authors:  Hongchao Wang; Bo Yang; Guangfei Hao; Yun Feng; Haiqin Chen; Lu Feng; Jianxin Zhao; Hao Zhang; Yong Q Chen; Lei Wang; Wei Chen
Journal:  Microbiology (Reading)       Date:  2011-08-18       Impact factor: 2.777

8.  The 1.25 A crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters.

Authors:  G Auerbach; A Herrmann; M Gütlich; M Fischer; U Jacob; A Bacher; R Huber
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

9.  Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability.

Authors:  Ling Gao; Yuh-Fen Pung; Jun Zhang; Peng Chen; Ting Wang; Min Li; Miguel Meza; Ligia Toro; Hua Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

10.  Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells.

Authors:  K Tanaka; S Kaufman; S Milstien
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.